Read all posts
www.nytimes.com

New Drug to Treat Obesity Gains Approval by F.D.A.

In a clinical trial involving patients without diabetes, those who took Contrave had an average weight loss of 4.1 percent beyond those receiving a placebo. About 42 percent of those getting Contrave lost at least 5 percent of their weight compared with 17 percent of patients in the placebo group.

Read the article on Nytimes

Dr. Sears Comments:

Dr. Barry Sears

The reason why the first two new obesity drugs have not sold well is because they don’t work effectively. This new drug should be no different. The only obesity drug that sold well was Fen-Phen because it shut down appetite very effectively. Of course, it had a few side effects like death, but it worked very well in those who didn’t die.

Leave a Reply

Your email address will not be published. Required fields are marked *